SOMFY - 2021 Half-year financial report

02 2021 CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

ANALYSIS OF CASH FLOW STATEMENT NOTE 10 — CASH AND CASH EQUIVALENTS NOTE 10.1

30/06/21 6 months 588,519 588,925

30/06/20 6 months 386,190 387,547

€ thousands

CASH AND CASH EQUIVALENTS AT THE START OF THE PERIOD

Cash and cash equivalents at the start of the period

Bank overdrafts

-405

-1,357

CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD

608,097 608,922

441,971 442,930

Cash and cash equivalents at the end of the period

Bank overdrafts

-825

-959

CHANGE IN WORKING CAPITAL REQUIREMENTS NOTE 10.2

30/06/21 6 months

30/06/20 6 months

€ thousands

Net decrease/(increase) in inventory

355

2,108

Net decrease/(increase) in trade receivables Net (decrease)/increase in trade payables Net movement in other receivables and payables CHANGE IN WORKING CAPITAL REQUIREMENTS

-89,452

-43,052

6,749 3,602

996 977

-78,746

-38,971

BUSINESS ACQUISITIONS AND DISPOSALS NET OF CASH ACQUIRED OR DISPOSED OF NOTE 10.3

Net cash flows from acquisitions included €27.5 million from the acquisition of Répar’stores (see note 4), €0.8 million from payment of the last earnout on Somfy Protect and €0.1 millionarising from the buyout of non-controlling interests from BFT India. Net cash flows from disposals correspond to the partial payment of current receivables onthe CIAT disposal (see “Highlights”).

PROVISIONS AND CONTINGENT LIABILITIES NOTE 11 — PROVISIONS NOTE 11.1

Non-current provisions Note 11.1.1

Provision for agents

Provisions for liabilities and charges

Total 2021

Provisions for guarantees

Provisions for litigation

€ thousands

9,645 1,665

At 1 January 2021

4,825

2,730

443

1,647

Charges

539 -59

899

18

209

-680 -432

Used reversals Unused reversals

-434

-47

-140

— -432

— — — —

— -3 — —

29 — —

Impact of foreign exchange rates

32 — —

— — —

Impact of changes in consolidation scope and method

Other movements AT 30 JUNE 2021

5,337

2,763

414

1,713

10,227

26

SOMFY – HALF-YEAR FINANCIAL REPORT 2021